JPWO2020053655A5 - - Google Patents

Download PDF

Info

Publication number
JPWO2020053655A5
JPWO2020053655A5 JP2021514091A JP2021514091A JPWO2020053655A5 JP WO2020053655 A5 JPWO2020053655 A5 JP WO2020053655A5 JP 2021514091 A JP2021514091 A JP 2021514091A JP 2021514091 A JP2021514091 A JP 2021514091A JP WO2020053655 A5 JPWO2020053655 A5 JP WO2020053655A5
Authority
JP
Japan
Prior art keywords
inhibitor
use according
breast cancer
subject
dimethylisoxazol
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2021514091A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022500435A (ja
JP2022500435A5 (https=
Publication date
Application filed filed Critical
Priority claimed from PCT/IB2019/001009 external-priority patent/WO2020053655A1/en
Publication of JP2022500435A publication Critical patent/JP2022500435A/ja
Publication of JPWO2020053655A5 publication Critical patent/JPWO2020053655A5/ja
Publication of JP2022500435A5 publication Critical patent/JP2022500435A5/ja
Pending legal-status Critical Current

Links

JP2021514091A 2018-09-13 2019-09-13 トリプルネガティブ乳癌の治療のための併用療法 Pending JP2022500435A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201862730879P 2018-09-13 2018-09-13
US62/730,879 2018-09-13
US201862737628P 2018-09-27 2018-09-27
US62/737,628 2018-09-27
PCT/IB2019/001009 WO2020053655A1 (en) 2018-09-13 2019-09-13 Combination therapy for the treatment of triple-negative breast cancer

Publications (3)

Publication Number Publication Date
JP2022500435A JP2022500435A (ja) 2022-01-04
JPWO2020053655A5 true JPWO2020053655A5 (https=) 2022-09-15
JP2022500435A5 JP2022500435A5 (https=) 2022-09-15

Family

ID=69777478

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021514091A Pending JP2022500435A (ja) 2018-09-13 2019-09-13 トリプルネガティブ乳癌の治療のための併用療法

Country Status (12)

Country Link
US (1) US11607405B2 (https=)
EP (1) EP3849549A4 (https=)
JP (1) JP2022500435A (https=)
KR (1) KR20210087440A (https=)
CN (1) CN112912077B (https=)
AU (1) AU2019337470A1 (https=)
CA (1) CA3111371A1 (https=)
IL (1) IL281256A (https=)
MX (1) MX2021002886A (https=)
SG (1) SG11202102483SA (https=)
TW (1) TWI816881B (https=)
WO (1) WO2020053655A1 (https=)

Families Citing this family (89)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10774374B2 (en) 2015-04-10 2020-09-15 Spatial Transcriptomics AB and Illumina, Inc. Spatially distinguished, multiplex nucleic acid analysis of biological specimens
CN115135984B (zh) 2019-12-23 2025-12-23 10X基因组学有限公司 可逆固定试剂及其使用方法
WO2021133849A1 (en) 2019-12-23 2021-07-01 10X Genomics, Inc. Methods for spatial analysis using rna-templated ligation
EP4081656A1 (en) 2019-12-23 2022-11-02 10X Genomics, Inc. Compositions and methods for using fixed biological samples in partition-based assays
CN115715329A (zh) 2020-01-10 2023-02-24 10X基因组学有限公司 确定生物样品中靶核酸位置的方法
US12365942B2 (en) 2020-01-13 2025-07-22 10X Genomics, Inc. Methods of decreasing background on a spatial array
US12405264B2 (en) 2020-01-17 2025-09-02 10X Genomics, Inc. Electrophoretic system and method for analyte capture
US11702693B2 (en) 2020-01-21 2023-07-18 10X Genomics, Inc. Methods for printing cells and generating arrays of barcoded cells
US11732299B2 (en) 2020-01-21 2023-08-22 10X Genomics, Inc. Spatial assays with perturbed cells
US20210230681A1 (en) 2020-01-24 2021-07-29 10X Genomics, Inc. Methods for spatial analysis using proximity ligation
US11821035B1 (en) 2020-01-29 2023-11-21 10X Genomics, Inc. Compositions and methods of making gene expression libraries
US11898205B2 (en) 2020-02-03 2024-02-13 10X Genomics, Inc. Increasing capture efficiency of spatial assays
US12110541B2 (en) 2020-02-03 2024-10-08 10X Genomics, Inc. Methods for preparing high-resolution spatial arrays
US11732300B2 (en) 2020-02-05 2023-08-22 10X Genomics, Inc. Increasing efficiency of spatial analysis in a biological sample
US11835462B2 (en) 2020-02-11 2023-12-05 10X Genomics, Inc. Methods and compositions for partitioning a biological sample
US12399123B1 (en) 2020-02-14 2025-08-26 10X Genomics, Inc. Spatial targeting of analytes
US12281357B1 (en) 2020-02-14 2025-04-22 10X Genomics, Inc. In situ spatial barcoding
US11891654B2 (en) 2020-02-24 2024-02-06 10X Genomics, Inc. Methods of making gene expression libraries
US11768175B1 (en) 2020-03-04 2023-09-26 10X Genomics, Inc. Electrophoretic methods for spatial analysis
ES2965354T3 (es) 2020-04-22 2024-04-12 10X Genomics Inc Métodos para análisis espacial que usan eliminación de ARN elegido como diana
CN116134308B (zh) 2020-05-19 2025-05-27 10X基因组学有限公司 电泳盒和仪器
EP4553168A3 (en) 2020-05-22 2025-08-27 10x Genomics, Inc. Spatial analysis to detect sequence variants
EP4153775B1 (en) 2020-05-22 2024-07-24 10X Genomics, Inc. Simultaneous spatio-temporal measurement of gene expression and cellular activity
WO2021237056A1 (en) 2020-05-22 2021-11-25 10X Genomics, Inc. Rna integrity analysis in a biological sample
WO2021242834A1 (en) 2020-05-26 2021-12-02 10X Genomics, Inc. Method for resetting an array
EP4025692A2 (en) 2020-06-02 2022-07-13 10X Genomics, Inc. Nucleic acid library methods
EP4158054B1 (en) 2020-06-02 2025-04-16 10X Genomics, Inc. Spatial transcriptomics for antigen-receptors
US12031177B1 (en) 2020-06-04 2024-07-09 10X Genomics, Inc. Methods of enhancing spatial resolution of transcripts
WO2021252499A1 (en) 2020-06-08 2021-12-16 10X Genomics, Inc. Methods of determining a surgical margin and methods of use thereof
US12435363B1 (en) 2020-06-10 2025-10-07 10X Genomics, Inc. Materials and methods for spatial transcriptomics
US20230279474A1 (en) 2020-06-10 2023-09-07 10X Genomics, Inc. Methods for spatial analysis using blocker oligonucleotides
EP4165207B1 (en) 2020-06-10 2024-09-25 10X Genomics, Inc. Methods for determining a location of an analyte in a biological sample
WO2021252747A1 (en) 2020-06-10 2021-12-16 1Ox Genomics, Inc. Fluid delivery methods
EP4172362B1 (en) 2020-06-25 2024-09-18 10X Genomics, Inc. Spatial analysis of dna methylation
US11761038B1 (en) 2020-07-06 2023-09-19 10X Genomics, Inc. Methods for identifying a location of an RNA in a biological sample
US12209280B1 (en) 2020-07-06 2025-01-28 10X Genomics, Inc. Methods of identifying abundance and location of an analyte in a biological sample using second strand synthesis
US20230287475A1 (en) 2020-07-31 2023-09-14 10X Genomics, Inc. De-crosslinking compounds and methods of use for spatial analysis
US12553898B1 (en) 2020-08-10 2026-02-17 10X Genomics, Inc. Fluorescent hybridization of antibody-oligonucleotide for multiplexing and signal amplification
US11981958B1 (en) 2020-08-20 2024-05-14 10X Genomics, Inc. Methods for spatial analysis using DNA capture
EP4530358A3 (en) 2020-09-15 2025-06-18 10x Genomics, Inc. Methods of releasing an extended capture probe from a substrate and uses of the same
AU2021345133A1 (en) 2020-09-16 2023-03-30 10X Genomics, Inc. Methods of determining the location of an analyte in a biological sample using a plurality of wells
US11926822B1 (en) 2020-09-23 2024-03-12 10X Genomics, Inc. Three-dimensional spatial analysis
AU2021385065A1 (en) 2020-11-18 2023-06-15 10X Genomics, Inc. Methods and compositions for analyzing immune infiltration in cancer stroma to predict clinical outcome
US11827935B1 (en) 2020-11-19 2023-11-28 10X Genomics, Inc. Methods for spatial analysis using rolling circle amplification and detection probes
EP4729631A2 (en) 2020-12-21 2026-04-22 10X Genomics, Inc. Methods, compositions, and systems for capturing probes and/or barcodes
WO2022147005A1 (en) 2020-12-30 2022-07-07 10X Genomics, Inc. Methods for analyte capture determination
US20240093290A1 (en) 2021-01-29 2024-03-21 10X Genomics, Inc. Method for transposase mediated spatial tagging and analyzing genomic dna in a biological sample
ES3008686T3 (en) 2021-03-18 2025-03-24 10X Genomics Inc Multiplex capture of gene and protein expression from a biological sample
WO2022226057A1 (en) 2021-04-20 2022-10-27 10X Genomics, Inc. Methods for assessing sample quality prior to spatial analysis using templated ligation
EP4320271B1 (en) 2021-05-06 2025-03-19 10X Genomics, Inc. Methods for increasing resolution of spatial analysis
EP4582555A3 (en) 2021-06-03 2025-10-22 10X Genomics, Inc. Methods, compositions, kits, and systems for enhancing analyte capture for spatial analysis
US20240368711A1 (en) 2021-06-22 2024-11-07 10X Genomics, Inc. Spatial detection of sars-cov-2 using templated ligation
EP4352252B1 (en) 2021-07-13 2026-01-28 10X Genomics, Inc. Methods for spatial analysis using targeted probe silencing
US12553805B2 (en) 2021-08-02 2026-02-17 10X Genomics, Inc. Methods of preserving a biological sample
WO2023018799A1 (en) 2021-08-12 2023-02-16 10X Genomics, Inc. Methods, compositions and systems for identifying antigen-binding molecules
ES3011462T3 (en) 2021-09-01 2025-04-07 10X Genomics Inc Methods for blocking a capture probe on a spatial array
TW202327594A (zh) * 2021-09-23 2023-07-16 大陸商恒翼生物醫藥(上海)股份有限公司 用bet溴結構域抑制劑和parp抑制劑的組合治療預選患者群體的三陰性乳腺癌的方法
WO2023086880A1 (en) 2021-11-10 2023-05-19 10X Genomics, Inc. Methods, compositions, and kits for determining the location of an analyte in a biological sample
WO2023102313A1 (en) 2021-11-30 2023-06-08 10X Genomics, Inc. Systems and methods for identifying regions of aneuploidy in a tissue
EP4305195A2 (en) 2021-12-01 2024-01-17 10X Genomics, Inc. Methods, compositions, and systems for improved in situ detection of analytes and spatial analysis
WO2023150171A1 (en) 2022-02-01 2023-08-10 10X Genomics, Inc. Methods, compositions, and systems for capturing analytes from glioblastoma samples
WO2023150163A1 (en) 2022-02-01 2023-08-10 10X Genomics, Inc. Methods, compositions, and systems for capturing analytes from lymphatic tissue
EP4479933A1 (en) 2022-02-15 2024-12-25 10x Genomics, Inc. Systems and methods for spatial analysis of analytes using fiducial alignment
WO2023215552A1 (en) 2022-05-06 2023-11-09 10X Genomics, Inc. Molecular barcode readers for analyte detection
WO2023229982A2 (en) 2022-05-24 2023-11-30 10X Genomics, Inc. Porous structure confinement for convection suppression
WO2023250077A1 (en) 2022-06-22 2023-12-28 10X Genomics, Inc. Methods, compositions, and systems for capturing probes and/or barcodes
WO2024035844A1 (en) 2022-08-12 2024-02-15 10X Genomics, Inc. Methods for reducing capture of analytes
EP4573208A1 (en) 2022-10-10 2025-06-25 10X Genomics, Inc. In vitro transcription of spatially captured nucleic acids
WO2024086167A2 (en) 2022-10-17 2024-04-25 10X Genomics, Inc. Methods, compositions, and kits for determining the location of an analyte in a biological sample
WO2024102809A1 (en) 2022-11-09 2024-05-16 10X Genomics, Inc. Methods, compositions, and kits for determining the location of multiple analytes in a biological sample
WO2024145441A1 (en) 2022-12-29 2024-07-04 10X Genomics, Inc. Methods, compositions, and kits for determining a location of a target nucleic acid in a fixed biological sample
EP4486913B1 (en) 2022-12-30 2025-07-16 10x Genomics, Inc. Methods, compositions, and kits for multiple barcoding and/or high-density spatial barcoding
WO2024145445A1 (en) 2022-12-30 2024-07-04 10X Genomics, Inc. Methods of capturing target analytes
EP4689174A1 (en) 2023-03-28 2026-02-11 10X Genomics, Inc. Methods, compositions, and kits for reducing analyte mislocalization
US20250257393A1 (en) 2023-04-21 2025-08-14 10X Genomics, Inc. Methods and compositions for detecting nucleic acids in a fixed biological sample
WO2024238900A1 (en) 2023-05-17 2024-11-21 10X Genomics, Inc. Methods of reducing mislocalization of an analyte
WO2024254316A1 (en) 2023-06-07 2024-12-12 10X Genomics, Inc. Compositions and methods for identifying blood clots in biological samples
EP4728062A1 (en) 2023-06-13 2026-04-22 10X Genomics, Inc. Sequence specific dna binding proteins
WO2025029605A1 (en) 2023-07-28 2025-02-06 10X Genomics, Inc. Methods and compositions for detecting genetic variants using capture probes and primer extension
WO2025029627A1 (en) 2023-07-31 2025-02-06 10X Genomics, Inc. Methods, compositions, and kits for spatial detection of genetic variants
EP4581160A1 (en) 2023-08-24 2025-07-09 10X Genomics, Inc. Methods, kits, and compositions for spatial detection of genetic variants
WO2025064893A1 (en) * 2023-09-20 2025-03-27 The Trustees Of Columbia University In The City Of New York Methods of reversing parp-resistance in cancer
WO2025072119A1 (en) 2023-09-26 2025-04-03 10X Genomics, Inc. Methods, compositions, and kits for detecting spatial chromosomal interactions
WO2025090912A1 (en) 2023-10-26 2025-05-01 10X Genomics, Inc. Spatial arrays containing reusable master probes
WO2025096581A1 (en) 2023-10-31 2025-05-08 10X Genomics, Inc. Methods of spatial analysis and single nuclei sequencing
WO2025101864A1 (en) 2023-11-09 2025-05-15 10X Genomics, Inc. Methods, compositions, and kits for reducing mislocalization of analytes in spatial analysis assays
WO2025101377A1 (en) 2023-11-09 2025-05-15 10X Genomics, Inc. Matrix-assisted spatial analysis of biological samples
WO2025255457A1 (en) 2024-06-07 2025-12-11 10X Genomics, Inc. Compositions and methods for improved on-target spatial profiling
WO2026024934A1 (en) 2024-07-25 2026-01-29 10X Genomics, Inc. Methods, compositions, and kits for spatial analysis by tagmentation

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2010004246A (es) * 2007-10-18 2010-04-30 Novartis Ag Inhibidores de csf-1r para el tratamiento de cancer y de enfermedades oseas.
WO2013097052A1 (en) * 2011-12-30 2013-07-04 Abbott Laboratories Bromodomain inhibitors
BR112015001838B1 (pt) * 2012-07-27 2022-10-25 Izumi Technology, Llc Composição de inibidor de efluxo
WO2014128655A1 (en) * 2013-02-25 2014-08-28 Aurigene Discovery Technologies Limited Substituted imidazo[4,5-c]quinoline derivatives as bromodomain inhibitors
CA2915838C (en) * 2013-06-21 2023-04-18 Zenith Epigenetics Corp. Bicyclic bromodomain inhibitors
JP2017503771A (ja) * 2013-12-10 2017-02-02 アッヴィ・インコーポレイテッド トリプルネガティブ乳癌を治療するためのベリパリブとカルボプラチンの組合せ
CA2969417A1 (en) * 2014-12-05 2016-06-09 H. Lee Moffitt Cancer Center And Research Institute, Inc. Bromodomain inhibitor as adjuvant in cancer immunotherapy
WO2017015027A1 (en) * 2015-07-20 2017-01-26 Mayo Foundation For Medical Education And Research Methods and materials for treating cancer
BR112018006689A2 (pt) * 2015-10-02 2018-10-09 Dana Farber Cancer Inst Inc terapia de combinação de inibidores de bromodomínio e bloqueio de ponto de controle
WO2018097977A1 (en) * 2016-11-22 2018-05-31 Gilead Sciences, Inc. Crystalline forms of a phosphate complex of a bet inhibitor

Similar Documents

Publication Publication Date Title
JPWO2020053655A5 (https=)
JP2022500435A5 (https=)
TWI730013B (zh) 用於治療癌症的四環喹諾酮類似物組合療法
WO2023190748A1 (ja) 腫瘍治療用医薬組成物
MX2021002886A (es) Terapia de combinacion para el tratamiento de cancer de mama triple negativo.
CN104203279B (zh) 脑癌的治疗
US11065240B2 (en) Drug combinations to treat multiple myeloma
ES2813649T3 (es) Composición farmacéutica administrable por vía oral para la prevención o el tratamiento del síndrome del ojo seco, que comprende rebamipida o un profármaco de la misma
JP2018184465A5 (https=)
JP2010523696A (ja) 脳腫瘍を治療する方法
CN107405404A (zh) 苏拉明和精氨酸酶抑制剂在恶性肿瘤中的用途
JP2021521222A (ja) 6,8−ビス−ベンジルチオ−オクタン酸を使用して前立腺癌を治療するための治療方法および組成物
US20100093773A1 (en) Methods of treating cancer
TW202038932A (zh) 使用6,8-雙-苄硫基-辛酸和自噬抑制劑治療癌症之治療方法及組成物
WO2017148129A1 (zh) 一种用于治疗恶病质的药物组合物及其应用
JPWO2022182857A5 (https=)
JP2022500431A5 (https=)
CN107073015B (zh) 用于治疗吸烟者中的非小细胞肺癌的维利帕尼与卡铂和紫杉醇的组合
JP2018522049A5 (https=)
CN113329749A (zh) 用于治疗葡萄膜黑色素瘤的联合疗法
Rodríguez-Cerdeira et al. Two different scenarios of advanced basal cell carcinomas during the use of vismodegib: Cases of oral administration and administration directly to the stomach
BR112015007870B1 (pt) Composição compreendendo derivado de 6-oxo-1,6-di-hidro-piridazina e inibidor de mek, e seus usos
JP2022500423A5 (https=)
US20220395575A1 (en) Combination therapy with protein kinase b activation inhibitor to treat cancer
TW202023568A (zh) 用於治療癌症之組合療法